Williams P D, Hottendorf G H, Bennett D B
J Pharmacol Exp Ther. 1986 Jun;237(3):919-25.
The initial event in the renal tubular reabsorption of nephrotoxic aminoglycosides involves binding to brush border membranes. This primary event was measured in renal brush border membrane vesicles prepared from rat renal cortex utilizing [3H]gentamicin. In order to gain structure-activity information regarding this interaction the effect of substances having chemical similarities to aminoglycosides (sugars, polyamines and amino acids) on gentamicin binding to brush border membranes was determined. Polyamino acids were found to possess the greatest inhibitory potency. In addition to polymers of cationic amino acids (lysine, ornithine, arginine and histidine), polymers of neutral (asparagine) and acidic (aspartic and glutamic acid) amino acids also exhibited inhibition of the membrane binding of gentamicin. Inasmuch as inhibition of renal membrane binding has the potential to decrease aminoglycoside nephrotoxicity, several polyamino acids that inhibited membrane binding were tested in vivo for potential protective activity vs. gentamicin- and amikacin-induced nephrotoxicity. Polyasparagine90 and polyaspartic acid100 inhibited gentamicin and amikacin nephrotoxicity completely when coadministered to rats with the aminoglycosides. Polylysine20 provided complete and partial inhibition of gentamicin and amikacin nephrotoxicity, respectively. Whereas in vivo distribution studies revealed that cortical levels of [3H]amikacin were elevated slightly by the coadministration of polyaspartic acid, brush border and basolateral membranes contained significantly lower levels of the aminoglycoside (46 and 41% inhibition, respectively). These results question the role of charge per se in the binding of aminoglycosides to renal membranes and further confirm the importance of membrane binding in the pathogenesis of aminoglycoside nephrotoxicity.
肾毒性氨基糖苷类药物肾小管重吸收的初始事件涉及与刷状缘膜结合。利用[3H]庆大霉素在从大鼠肾皮质制备的肾刷状缘膜囊泡中测量了这一主要事件。为了获得有关这种相互作用的构效关系信息,测定了与氨基糖苷类药物具有化学相似性的物质(糖、多胺和氨基酸)对庆大霉素与刷状缘膜结合的影响。发现多氨基酸具有最大的抑制效力。除了阳离子氨基酸(赖氨酸、鸟氨酸、精氨酸和组氨酸)的聚合物外,中性(天冬酰胺)和酸性(天冬氨酸和谷氨酸)氨基酸的聚合物也表现出对庆大霉素膜结合的抑制作用。鉴于抑制肾膜结合有可能降低氨基糖苷类药物的肾毒性,对几种抑制膜结合的多氨基酸进行了体内试验,以检测其对庆大霉素和阿米卡星诱导的肾毒性的潜在保护活性。当与氨基糖苷类药物共同给予大鼠时,聚天冬酰胺90和聚天冬氨酸100完全抑制了庆大霉素和阿米卡星的肾毒性。聚赖氨酸20分别对庆大霉素和阿米卡星的肾毒性提供了完全和部分抑制。虽然体内分布研究表明,共同给予聚天冬氨酸会使[3H]阿米卡星的皮质水平略有升高,但刷状缘膜和基底外侧膜中的氨基糖苷类药物水平显著降低(分别抑制46%和41%)。这些结果质疑了电荷本身在氨基糖苷类药物与肾膜结合中的作用,并进一步证实了膜结合在氨基糖苷类药物肾毒性发病机制中的重要性。